✦ LIBER ✦

Bortezomib-dexamethasone combination in a patient with refractory multiple myeloma and impaired renal function

✍ Scribed by Andrea Nozza; Licia Siracusano; Santoro Armando

Book ID: 116371859
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 816 KB
Volume: 28
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2006.06.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bortezomib in recurrent and/or refractor

Bortezomib in recurrent and/or refractory multiple myeloma : Initial clinical experience in patients with impaired renal function

✍ Sundar Jagannath; Bart Barlogie; James R. Berenson; Seema Singhal; Raymond Alexa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 1 views

Bortezomib and Dexamethasone Therapy for

Bortezomib and Dexamethasone Therapy for Newly Diagnosed Patients With Multiple Myeloma Complicated by Renal Impairment

✍ Jian Li; Dao-Bin Zhou; Li Jiao; Ming Hui Duan; Wei Zhang; Yong Qiang Zhao; Ti Sh 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 673 KB

Bortezomib in combination with thalidomi

Bortezomib in combination with thalidomide and dexamethasone—a successful treatment regimen in refractory extramedullary multiple myeloma

✍ Dominik Dytfeld; Magdalena Matuszak; Krzysztof Lewandowski; Mieczysław Komarnick 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 84 KB

Lenalidomide in combination with dexamet

Lenalidomide in combination with dexamethasone: effective regimen in patients with relapsed or refractory multiple myeloma complicated by renal impairment

✍ Ulrike Klein; Kai Neben; Thomas Hielscher; Christiane Heiß; Anthony D. Ho; Hartm 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 204 KB

VTD combination therapy with bortezomib–

VTD combination therapy with bortezomib–thalidomide–dexamethasone is highly effective in advanced and refractory multiple myeloma

✍ Pineda-Roman, M; Zangari, M; van Rhee, F; Anaissie, E; Szymonifka, J; Hoering, A 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 279 KB

Outcomes of patients with multiple myelo

Outcomes of patients with multiple myeloma and renal impairment treated with bortezomib, cyclophosphamide, and dexamethasone without plasma exchange

✍ Luciano J. Costa; Jonathan Abbas; Karen L. Ortiz-Cruz; Yubin Kang; Robert K. Stu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB